Genenta Science SpA Sponsored ADR (GNTA) has released an update.
Genenta Science SpA, a biotech company based in Milan, is focused on the research, development, and sale of biotechnological and pharmaceutical compounds in various medical and diagnostic fields. The firm has provisions to increase its share capital through various methods, including shareholder contributions and the issuance of new shares, with an emphasis on funding its expansion and innovative projects. The company’s by-laws also permit the establishment of offices both in Italy and internationally, and its corporate term is set until December 31, 2050.
For further insights into GNTA stock, check out TipRanks’ Stock Analysis page.
